AN UPDATE ON RECENT ADVANCES IN NANOEMULSION BASED HYDROGELS: NANOEMULGELS

Q3 Pharmacology, Toxicology and Pharmaceutics
Lakshmi Usha, Ayalasomayajula, C. S. Patro, A. Bhavani, B.Murali Krishna, A. V. Murty
{"title":"AN UPDATE ON RECENT ADVANCES IN NANOEMULSION BASED HYDROGELS: NANOEMULGELS","authors":"Lakshmi Usha, Ayalasomayajula, C. S. Patro, A. Bhavani, B.Murali Krishna, A. V. Murty","doi":"10.47750/pnr.2023.14.02.336","DOIUrl":null,"url":null,"abstract":"The newly developed lipophilic drug molecules encounter problems like availability of less amount of drug at the site of action, unpredictable absorption, etc. To overcome these disadvantages, enhancement of solubility and development of novel formulation is a continuous process. Recent advances in technology had helped in developing novel nanoparticulate topical delivery systems. Their characteristic properties such as nano droplet size i.e. 20-200nm, high interfacial area, transparent, translucent appearance, capability to freely solublise in water, high kinetic stability, sedimentation, flocculation and coalescence created a new era in the development nanoparticulate topical drug delivery systems with increased applications. The most advantageous thing about topical nanoemulsion is that it can penetrate and permeate the skin membrane without incorporation of a permeation enhancer. Various studies revealed that the activity of anti inflammatory and anti fungal drugs have been increased as topical nano preparations i.e. nanoemulsions and nanoemulgels with compared to conventional emulsions and emulgels. Nanoemulgels are nanoemulsion based hydrogels prepared by adding nanoemulsion to the hydrogel matrix. The inability of hydrogels led to the development of nanoemugels which solublises the lipophilic drug in the oily phase of the emulsion followed by the addition of this mixture into a gel base.","PeriodicalId":16728,"journal":{"name":"Journal of Pharmaceutical Negative Results","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmaceutical Negative Results","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47750/pnr.2023.14.02.336","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

The newly developed lipophilic drug molecules encounter problems like availability of less amount of drug at the site of action, unpredictable absorption, etc. To overcome these disadvantages, enhancement of solubility and development of novel formulation is a continuous process. Recent advances in technology had helped in developing novel nanoparticulate topical delivery systems. Their characteristic properties such as nano droplet size i.e. 20-200nm, high interfacial area, transparent, translucent appearance, capability to freely solublise in water, high kinetic stability, sedimentation, flocculation and coalescence created a new era in the development nanoparticulate topical drug delivery systems with increased applications. The most advantageous thing about topical nanoemulsion is that it can penetrate and permeate the skin membrane without incorporation of a permeation enhancer. Various studies revealed that the activity of anti inflammatory and anti fungal drugs have been increased as topical nano preparations i.e. nanoemulsions and nanoemulgels with compared to conventional emulsions and emulgels. Nanoemulgels are nanoemulsion based hydrogels prepared by adding nanoemulsion to the hydrogel matrix. The inability of hydrogels led to the development of nanoemugels which solublises the lipophilic drug in the oily phase of the emulsion followed by the addition of this mixture into a gel base.
纳米乳液水凝胶研究进展
新开发的亲脂性药物分子遇到了作用部位药物用量少、吸收不可预测等问题。为了克服这些缺点,提高溶解度和开发新制剂是一个连续的过程。最近的技术进步有助于开发新型纳米颗粒局部递送系统。它们的特性,如纳米液滴尺寸(即20-200nm)、高界面面积、透明、半透明的外观、在水中自由溶解的能力、高动力学稳定性、沉淀、絮凝和聚结,开创了纳米颗粒局部给药系统开发的新时代,并增加了应用。局部纳米乳液最有利的是,它可以在不掺入渗透促进剂的情况下渗透和渗透皮肤膜。各种研究表明,与传统乳液和乳液相比,作为局部纳米制剂,即纳米乳液和纳米乳液,抗炎和抗真菌药物的活性已经提高。纳米乳液凝胶是通过将纳米乳液添加到水凝胶基质中制备的基于纳米乳液的水凝胶。水凝胶的无能导致了纳米凝胶的发展,它将亲脂性药物溶解在乳液的油相中,然后将这种混合物加入凝胶基质中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信